Daridorexant, marketed as Quviviq, has a list price of $165 for a 30-day supply [1]. This price applies to both the 25 mg and 50 mg dosage strengths [1].
How much does Quviviq cost with insurance?
Insurance coverage and out-of-pocket costs for Quviviq can vary significantly depending on the specific insurance plan. Some patients may have copay assistance programs available through the manufacturer, Idorsia Pharmaceuticals [1]. The Quviviq Copay Card offers eligible commercially insured patients a $0 copay for their first prescription and a $10 copay for subsequent refills for up to 12 months, with a maximum savings of $75 per prescription and $900 annually [1].
What is the active ingredient in Quviviq?
The active ingredient in Quviviq is daridorexant [1]. Daridorexant is a dual orexin receptor antagonist that works by blocking the wake-promoting neuropeptides orexin A and orexin B [2]. This action reduces the drive for wakefulness, thereby helping to initiate and maintain sleep [2].
What is daridorexant used to treat?
Daridorexant is approved for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults [1]. It is designed to address the underlying mechanism of wakefulness, rather than acting as a traditional sedative [2].
When did daridorexant get approved?
Daridorexant received U.S. Food and Drug Administration (FDA) approval in January 2022 [3].
Who manufactures daridorexant?
Daridorexant is manufactured by Idorsia Pharmaceuticals [1].
Are there any patient assistance programs for Quviviq?
Yes, Idorsia Pharmaceuticals offers a Quviviq Copay Card program for eligible commercially insured patients. This program can reduce out-of-pocket costs, potentially offering a $0 copay for the initial prescription and a $10 copay for refills, subject to program limits [1].
Sources:
[1] https://www.drugpatentwatch.com/drug/daridorexant/2778
[2] https://www.drugpatentwatch.com/drug/daridorexant/2778
[3] https://www.drugpatentwatch.com/drug/daridorexant/2778